Box score
Accipiter Biosciences Inc.
Reported $10.5M sold in a new Form D filed July 28, 2026 (Seattle, Washington).
- Biggest raise
- $10.5M filed Jul 28, 2026
- League
- Bio & Health Biotechnology
- Based in
- Seattle, Washington
- Season rank
- #190 of 1,121 in the Bio & Health League; #1684 of 10,745 overall (2026)
- Incorporated
- 2023
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-07-28 | New notice | $10.5M | $10.5M | SEC |
| 2025-09-24 | Amendment | $13.6M | $13.7M | SEC |
| 2024-05-28 | New notice | $7.9M | $13.7M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1973963.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | CytoDyn Inc. | Bio & Health | $18.6M |
| 2 | Pluristyx Inc. rookie provisional | Bio & Health | $9.8M |
| 3 | Solius Labs, Inc. | Bio & Health | $3.5M |
| 4 | Aptevo Therapeutics Inc. | Bio & Health | $3.5M |
| 5 | Key Proteo, Inc. | Bio & Health | $2.3M |
| 6 | Strella Biotechnology, Inc. provisional | Bio & Health | $1.8M |